ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975

Quality Of Care Varies Widely For Prostate Cancer, Study Says

August 29, 2008

In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says

November 27, 1981

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014